Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael C. Perry
Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Influence of Substituents on the 13c-NMR Chemical Shifts of Meta- And Para- Substituted Phenylacetylenes
Designed Monomers and Polymers
Polymers
Materials Chemistry
Chemistry
Chemical Engineering
Plastics
Related publications
Eastern Cooperative Oncology Group Experience With Chemotherapy in Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Pcn197 - Cost Utility Analysis of First-Line Paclitaxel With Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab Versus Pemetrexed With Carboplatin Followed by Maintenance Pemetrexed in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer in Lebanon
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-87 a Phase 1b Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Patients With Stage 4 Non-Squamous Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Randomized Phase II Study of Cetuximab and Bevacizumab in Combination With Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase II Trial of Gefitinib in Combination With Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer With Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Induction of Peripheral Effector CD8 T Cell Proliferation by Combination of Paclitaxel, Carboplatin and Bevacizumab in Non-Small Cell Lung Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
